Newsroom

Blog

How does medical purpose drive regulatory requirements in EU clinical trials?

Clear and accurate assessment of whether use of an assay in a clinical trial assay is considered exploratory or an “IVD” is necessary as implications extend to quality/regulatory pathways, assay de

Read More
Written By:
JamesYen.jpg
James Yen

FedEx Express National Service Disruption: Severe Winter Weather

FedEx Express experienced substantial disruptions at their Memphis and Indianapolis hubs last night due to severe winter weather that has been moving across the United States.

Read More

Lite Paper: Real-World PD-L1 Testing Data Provides Insight into the Evolving Immuno-oncology Landscape

Case Study: How Pharma Uses NeoGenomics Real-World Oncology Data to Accelerate Biomarker Adoption and Commercial Launch

The Breakroom Video Series

NeoGenomics is proud to share the Breakroom video series.

Read More

Taking Spatial Toward the Clinic: DeciBio’s Q&A with Sandy Au of NeoGenomics

Blog originally posted on Decibio Insights here.

Read More

Is IHC going to exhaust our archival blocks the way single gene testing used to?

Over the past year we have seen unprecedented demand for IHC assay development services with the goal of creating a prototype CDx assay.

Read More
Written By:
scottreid.jpg
Scott Reid

NeoGenomics announces speaker program, ‘Minimal Residual Disease in Colorectal Cancer’

NeoGenomics is pleased to announce a speaker program titled ‘Minimal Residual Disease in Colorectal Cancer.’

Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients